Related Experiment Video
Updated: Jul 19, 2026
04:15
A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
Published on: February 2, 2024
Integrin antagonists as therapeutics for inflammatory diseases.
Peter Vanderslice1, Darren G Woodside
1Encysive Pharmaceuticals, Department of Drug Discovery, Biological Sciences, 7000 Fannin, 19th Floor, Houston, TX 77030, USA. pvanderslice@encysive.com
Expert Opinion on Investigational Drugs
|September 23, 2006
Summary
Integrins are cell receptors involved in immune responses and diseases. Targeting specific integrins with therapies shows promise for treating inflammatory conditions like pulmonary, skin, and rheumatic disorders.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Integrins are cell surface receptors mediating crucial cellular adhesion.
- While vital for immune responses, integrins also drive inflammatory and autoimmune diseases.
- Their role in disease has attracted significant pharmaceutical interest.
Purpose of the Study:
- To review integrin subclasses evaluated for inflammatory diseases.
- To discuss therapeutic strategies targeting integrins.
- To explore future directions in integrin-targeted drug development.
Main Methods:
- Review of scientific literature on integrin function and therapeutic targeting.
- Focus on alpha4, beta2, and collagen-binding integrin families.
- Analysis of approved therapies and drugs in development.
Main Results:
- Humanized monoclonal antibodies targeting integrins have shown clinical success.
- This validates integrins as therapeutic targets for various diseases.
- Specific integrin subclasses are under investigation for pulmonary, dermatological, gastrointestinal, and rheumatic conditions.
Conclusions:
- Targeting integrins offers effective therapeutic strategies for inflammatory and autoimmune disorders.
- Small-molecule antagonists are a promising development area.
- Interference with integrin signaling pathways represents a key future research focus.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...